Immuno-oncology innovations redefining cancer treatment in 2024
Drug Target Review
JANUARY 23, 2024
Cell-based therapies, such as tumour-infiltrating lymphocyte (TIL) therapy, have also drawn significant attention following promising results in a melanoma trial. Such approaches apply artificial intelligence (AI) and machine learning (ML) to predict mutations most likely to be good targets for the immune system.
Let's personalize your content